RNA Therapeutic for ADKPD | Kidney Disease

PYC Therapeutic

This video provides an overview of Autosomal dominant polycystic kidney disease (ADKPD) and the mechanism of action (MoA) of PYC’s mRNA therapeutic candidate, PYC-003.

Previous
Previous

Enzyme Technology / IFF

Next
Next

RNA Therapeutic for ADOA, Eye Disease / MoA / PYC Therapeutics